XML 36 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Quarterly Financial Data (unaudited)
 12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (unaudited)

15. Quarterly Financial Data (unaudited)

The following table presents certain unaudited quarterly financial information. This information has been prepared on the same basis as the audited consolidated financial statements and includes all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the unaudited quarterly results of operations set forth herein.

 

 

 

2018

 

 

2017

 

 

 

Q1

 

 

Q2

 

 

Q3

 

 

Q4

 

 

Q1

 

 

Q2

 

 

Q3

 

 

Q4

 

Product revenue, net

 

$

606

 

 

$

2,265

 

 

$

7,176

 

 

$

14,070

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Collaboration and license revenue

 

$

6,038

 

 

$

1,746

 

 

$

7,001

 

 

$

1,228

 

 

$

5,128

 

 

$

3,787

 

 

$

3,828

 

 

$

9,803

 

Operating expenses

 

$

(91,944

)

 

$

(107,706

)

 

$

(83,321

)

 

$

(102,479

)

 

$

(45,666

)

 

$

(69,621

)

 

$

(84,284

)

 

$

(95,654

)

Net loss

 

$

(84,510

)

 

$

(105,971

)

 

$

(71,177

)

 

$

(88,886

)

 

$

(41,764

)

 

$

(69,414

)

 

$

(82,941

)

 

$

(91,501

)

Net loss (income) attributable to noncontrolling interest (SRX Cardio)

 

$

332

 

 

$

(223

)

 

$

(126

)

 

$

338

 

 

$

45

 

 

$

(240

)

 

$

5

 

 

$

(280

)

Net loss attributable to Portola

 

$

(84,178

)

 

$

(106,194

)

 

$

(71,303

)

 

$

(88,548

)

 

$

(41,719

)

 

$

(69,654

)

 

$

(82,936

)

 

$

(91,781

)

Net loss per share attributable to Portola common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(1.28

)

 

$

(1.61

)

 

$

(1.08

)

 

$

(1.34

)

 

$

(0.74

)

 

$

(1.22

)

 

$

(1.41

)

 

$

(1.41

)